share_log

NeuroBo Pharmaceuticals Q1 2024 GAAP EPS $(1.32) Misses $(1.10) Estimate

Benzinga ·  May 9 08:47

NeuroBo Pharmaceuticals (NASDAQ:NRBO) reported quarterly losses of $(1.32) per share which missed the analyst consensus estimate of $(1.10) by 20 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment